Healthy volunteers needed to test safety of experimental drug LY3985297
NCT ID NCT06395012
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 18 times
Summary
This early-stage study tested whether the experimental drug LY3985297 is safe and tolerable in 140 healthy adults. Participants received either a single dose or multiple doses through an IV or injection under the skin. The study measured side effects and how the drug moves through the body. No treatment benefit was expected, as the goal was purely to gather safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel ACT
Anaheim, California, 92801, United States
-
ICON
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.